查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
神经復健市场：2023年至2028年预测
市场调查报告书
商品编码
1410026

神经復健市场：2023年至2028年预测

Neurorehabilitation Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计神经復健市场在预测期内将以 5.79% 的复合年增长率成长。

神经復健是指旨在促进受神经系统疾病或灾难影响的患者的实际康復、重建多功能性和解决个人满意度的各种治疗、调解和硬体。Masu。中风、脊髓损伤、帕金森氏症感染疾病、不同的硬化症和不同的问题都可能在其中。

由于神经系统疾病復发率的增加、机器的加强以及政府的持续努力，神经復健的市场规模正在快速成长。随着该领域的建立，调查方法和硬体有进一步进步的巨大潜力，最终为神经病变患者带来改善的结果和更好的生活。

市场驱动因素

神经系统疾病盛行率增加：

随着中风、心肌梗塞和硬化症等神经系统疾病发生率的增加，人们对神经復健药物的兴趣也随之增加。市场扩张背后的驱动力是不断扩大的患者群体对有效康復解决方案的需求不断增长。

復健设备的技术进步：

机器人外骨骼、脑机介面和虚拟实境系统等先进復健技术已经彻底改变了神经復健。这些最先进的仪器提供精准和客製化的治疗活动，吸引了医疗服务专业人员并鼓励了商业领域的发展。

越来越关注功能恢復和生活品质：

人们越来越关注改善神经系统感染疾病患者的实际康復和提高个人满意度。神经復健透过提供全面的復健计划，导致需求增加和市场扩张，在实现这些目标方面发挥关键作用。

神经復健市场的主要企业

  • 美敦力公司（Medtronic PLC）：美敦力公司是一家全球临床创新供应商，提供全面的神经復健设备和治疗方法。神经刺激框架、植入式设备和其他治疗神经系统疾病的新答案对该公司的产品组合非常重要。
  • DIH 医疗集团： DIH 的子公司 Hocoma AG 生产基于感测器的神经復健系统。该公司的贡献包括自动化治疗框架、扩增实境阶段以及用于上肢和下肢復健的感测器辅助復健设备。
  • Saebo赛博有限公司是一家专门从事上肢復健设备及解决方案的公司。我们提供有助于改善手部和手臂功能的产品，例如功能性矫正器具和机器人治疗系统。

预计北美将占据神经復健市场的重要份额。

由于多种因素，预计北美将占据很大的市场占有率。首先，该地区拥有先进的医疗基础设施，包括专门的復健中心和研究机构，鼓励使用神经復健技术。此外，神经系统疾病在北美很常见，这增加了对适当復健方法的需求。此外，有利的报销法规和促进神经復健的政府活动也有助于提高该地区的神经復健市场占有率。此外，北美是一些重要公司的所在地，这些公司在研发业务上的持续支出正在加强他们在神经復健市场的地位。

主要进展：

  • 2023 年 2 月，Lupin Limited 在孟买开设了世界上第一个电脑和机器人神经復健中心 Atharv Benefit。该中心为脊髓和脑损伤以及帕金森氏症、多发性脑性麻痹系统疾病患者提供復健计画。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 调查过程

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 市场机会
  • 波特五力分析
  • 产业价值链分析

第五章神经復健市场：副产品

  • 介绍
  • 神经机器人系统
  • 穿戴式装置
  • 脑机介面
  • 非侵入式模拟器
  • 神经假体
  • 其他的

第六章神经復健市场：依应用分类

  • 介绍
  • 中风
  • 创伤性脑损伤 (TBI)
  • 脊髓损伤（SCI）
  • 帕金森氏症
  • 脑性麻痹
  • 其他的

第七章神经復健市场：依最终用户分类

  • 介绍
  • 医院
  • 诊所
  • 復健中心
  • 居家照护环境

第八章神经復健市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第十章 公司简介

  • Medtronic PLC
  • Abbott Laboratories
  • BIONIK
  • Ekso Bionics Holdings Inc.
  • DIH Medical Group
  • ReWalk Robotics
  • BioXtreme Ltd.
  • Kinova
  • Saebo Inc.
简介目录
Product Code: KSI061615682

The neurorehabilitation market is estimated to grow at a CAGR of 5.79% during the forecast period.

Neurorehabilitation alludes to different treatments, mediations, and hardware that are planned to advance utilitarian recuperation, reestablish versatility, and work on personal satisfaction in patients experiencing neurological illnesses or mishaps. Stroke, spinal rope injury, Parkinson's infection, different sclerosis, and different issues might be among them.

The Neurorehabilitation market size is growing quickly, attributable to an expansion in the recurrence of neurological illnesses, mechanical enhancements, and steady government endeavors. As the discipline is created, there is huge potential for extra advances in neurorehabilitation methodology and hardware, eventually prompting improved results and a better life for those with neurological impedances.

Market Drives:

Increasing Prevalence of Neurological Disorders:

As the rate of neurological ailments like stroke, horrendous mind injury, and numerous cases of sclerosis rises, so does the interest in neurorehabilitation medicines. Market expansion is driven by the growing demand for effective rehabilitation solutions from this expanding patient population.

Technological Advancements in Rehabilitation Devices:

Advanced rehabilitation technologies like robotic exoskeletons, brain-computer interfaces, and virtual reality systems have revolutionized neurorehabilitation. These state-of-the-art contraptions convey precise and customized treatment activities, tempting medical services experts and impelling business sector development.

Growing Focus on Functional Recovery and Quality of Life:

There is a developing accentuation on upgrading practical recuperation and working on personal satisfaction for those with neurological infections. By providing comprehensive rehabilitation programs, neurorehabilitation plays a crucial role in achieving these goals, leading to increased demand and market expansion.

Key Players in the Neurorehabilitation Market:

  • Medtronic PLC: Medtronic is a worldwide clinical innovation supplier that gives an exhaustive scope of neurorehabilitation gear and treatments. Neurostimulation frameworks, implantable gadgets, and other new answers for the treatment of neurological ailments are important for their portfolio.
  • DIH Medical Group: DIH's subsidiary Hocoma AG manufactures sensor-based neurorehabilitation systems. Automated treatment frameworks, augmented reality stages, and sensor-helped restoration gear for upper and lower appendage recovery are among their contributions.
  • Saebo Inc.: Saebo is a company that specializes in upper limb rehabilitation equipment and solutions. They provide several goods, including functional orthoses and robotic treatment systems, to help people with neurological problems improve their hand and arm function.

North America is anticipated to hold a considerable neurorehabilitation market share.

North America is projected to account for a significant market share which is attributable to various factors. Firstly, the region contains sophisticated healthcare infrastructure, such as specialized rehabilitation centers and research organizations, which encourage the use of neurorehabilitation technology. Also, neurological illnesses are common in North America, increasing the requirement for appropriate rehabilitation methods. Furthermore, favorable reimbursement regulations and government activities promoting neurorehabilitation contribute to the region's neurorehabilitation market share. Furthermore, the presence of significant companies in North America, as well as continuing expenditures in research and development operations, reinforce its market position in the Neurorehabilitation market.

Key Developments:

  • In February 2023, Lupin Limited launched the first-of-its-kind computer and robotic-assisted Neurorehabilitation Center "Atharv Ability" in Mumbai. The center would provide rehabilitation programs for patients suffering from spinal cord & brain injury and other neurological conditions such as Parkinson's, multiple sclerosis, and cerebral palsy.

Segmentation

BY PRODUCT

  • Neuro-Robotic System
  • Wearable Devices
  • Brain Computer Interface
  • Non-Invasive Stimulators
  • Neuronal Prosthetics
  • Others

BY APPLICATION

  • Stroke
  • Traumatic Brain Injury (TBI)
  • Spinal Cord Injury (SCI)
  • Parkinson's Disease
  • Cerebral Palsy
  • Others

BY END-USER

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Home Care Settings

BY Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Market Opportunities
  • 4.4. Porter's Five Force Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of New Entrants
    • 4.4.4. Threat of Substitutes
    • 4.4.5. Competitive Rivalry in the Industry
  • 4.5. Industry Value Chain Analysis

5. NEUROREHABILITATION MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Neuro-Robotic System
  • 5.3. Wearable Devices
  • 5.4. Brain-Computer Interface
  • 5.5. Non-Invasive Simulators
  • 5.6. Neuronal Prosthetics
  • 5.7. Others

6. NEUROREHABILITATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Stroke
  • 6.3. Traumatic Brain Injury (TBI)
  • 6.4. Spinal Cord Injury (SCI)
  • 6.5. Parkinson's Disease
  • 6.6. Cerebral Palsy
  • 6.7. Others

7. NEUROREHABILITATION MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Rehabilitation Centers
  • 7.5. Home Care Settings

8. NEUROREHABILITATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Taiwan
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Medtronic PLC
  • 10.2. Abbott Laboratories
  • 10.3. BIONIK
  • 10.4. Ekso Bionics Holdings Inc.
  • 10.5. DIH Medical Group
  • 10.6. ReWalk Robotics
  • 10.7. BioXtreme Ltd.
  • 10.8. Kinova
  • 10.9. Saebo Inc.